This inventor holds 2 USPTO granted patents. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Inventor Li Li in Medical Research
Introduction
Li Li is a prominent inventor based in New York, NY (US), known for his significant contributions to medical research. He holds 2 patents that focus on innovative treatments for fibrosis and cancer. His work has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
Li Li's latest patents include HCK inhibitors for the treatment of fibrosis and cancer. These patents disclose compounds that are oxadiazaborole derivatives, which are inhibitors of hematopoietic cell kinase (HCK). These compounds exhibit anti-fibrotic and anti-proliferative effects, making them useful in treating various disorders, including renal fibrosis. Additionally, he has developed compounds that are thiazole and triazole derivatives, which also serve as HCK inhibitors with similar therapeutic applications.
Career Highlights
Li Li is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Collaborations
Li collaborates with esteemed colleagues, including Barbara Murphy and Chengguo Wei, who contribute to his research endeavors.
Conclusion
Li Li's innovative work in developing HCK inhibitors represents a significant advancement in the treatment of fibrosis and cancer. His contributions to medical research continue to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile